Author

Catherine Weiss

Observed names: C. Weiss, Catherine Weiss, PhD, Weiss, Catherine

Observed institutions: University Health Network, Lundbeck (Denmark), University of Toronto, Otsuka (United States), Massachusetts General Hospital, Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)

ORCID: 0000-0001-6712-4620

Observed ORCID: 0000-0001-6712-4620

OpenAlex ID: A5032296107

The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey

2020 · Rajiv Tandon, William R. Lenderking, et al. · Annals of General Psychiatry · 81

PDF

Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia

2016 · John M. Kane, Aleksandar Skuban, et al. · Schizophrenia Research · 68

PDF

Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies

2016 · Christoph U. Correll, Aleksandar Skuban, et al. · Schizophrenia Research · 59

Patient-reported outcome measures for life engagement in mental health: a systematic review

2022 · Roger S. McIntyre, Zahinoor Ismail, et al. · Journal of Patient-Reported Outcomes · 53

PDF

Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials

2016 · Roger S. McIntyre, Emmanuelle Weiller, et al. · Journal of Affective Disorders · 37

Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies

2016 · Stephen R. Marder, Mika Juhani Hakala, et al. · Acta Neuropsychiatrica · 36

Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies

2019 · Michael E Thase, Peter Zhang, et al. · Expert Opinion on Pharmacotherapy · 31

PDF

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

2018 · Michael E Thase, Emmanuelle Weiller, et al. · Neuropsychiatric Disease and Treatment · 31

PDF

Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder

2018 · Rajnish Mago, Andrea Fagiolini, et al. · BMC Psychiatry · 31

PDF

The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder

2018 · Catherine Weiss, Emmanuelle Weiller, et al. · International Clinical Psychopharmacology · 30

PDF

Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies

2018 · John W. Newcomer, Hans Eriksson, et al. · Current Medical Research and Opinion · 27

PDF

Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews

2021 · Catherine Weiss, Stine R. Meehan, et al. · Journal of Patient-Reported Outcomes · 26

PDF

Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

2016 · James Nelson, Peter Zhang, et al. · Current Psychiatry Reviews · 23

Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale

2018 · Mary Hobart, Peter Zhang, et al. · The International Journal of Neuropsychopharmacology · 19

Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies

2017 · J. Craig Nelson, Emmanuelle Weiller, et al. · Journal of Affective Disorders · 19

PDF

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

2017 · Emmanuelle Weiller, Catherine Weiss, et al. · Neuropsychiatric Disease and Treatment · 17

PDF

Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies

2020 · Nicole Meade, Lily Shi, et al. · Journal of Psychopharmacology · 16

PDF

Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study

2018 · Christoph U. Correll, Lily Shi, et al. · CNS Spectrums · 16

PDF

Changes in Metabolic Parameters and Body Weight in Patients With Major Depressive Disorder Treated With Adjunctive Brexpiprazole

2019 · John W. Newcomer, Hans Eriksson, et al. · The Journal of Clinical Psychiatry · 15

PDF

Effect of Brexpiprazole on Agitation and Hostility in Patients With Schizophrenia

2019 · Leslie Citrome, John Ouyang, et al. · Journal of Clinical Psychopharmacology · 13

Efficacy of Brexpiprazole as Adjunctive Treatment in Major Depressive Disorder With Irritability

2017 · Maurizio Fava, Emmanuelle Weiller, et al. · Journal of Clinical Psychopharmacology · 13

Assessment of patient life engagement in major depressive disorder using items from the Inventory of Depressive Symptomatology Self-Report (IDS-SR)

2023 · Michael E. Thase, Zahinoor Ismail, et al. · Journal of Psychiatric Research · 12

Exploring life engagement from the perspective of patients with major depressive disorder: a study using patient interviews

2022 · François Therrien, Stine R. Meehan, et al. · Journal of Patient-Reported Outcomes · 11

PDF

Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview

2016 · Michael E. Thase, Peter Zhang, et al. · Current Psychiatry Reviews · 10

Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies

2021 · Stephen R Marder, Stine R Meehan, et al. · Schizophrenia Bulletin Open · 9

PDF

Works count: 67

Citation count: 749

H-index: 16

I10-index: 24